FDCP
BSX icon

Foster Dykema Cabot & Partners’s Boston Scientific BSX Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Hold
400
– – ﹤0.01% 245
2026
Q1 		$25.1K Hold
400
– – ﹤0.01% 218
2025
Q4 		$38.1K Sell
400
-95
-19% -$9.31K ﹤0.01% 208
2025
Q3 		$48.3K Hold
495
– – ﹤0.01% 213
2025
Q2 		$53.2K Hold
495
– – ﹤0.01% 194
2025
Q1 		$49.9K Sell
495
-24
-5% -$2.42K ﹤0.01% 191
2024
Q4 		$46.4K Hold
519
– – ﹤0.01% 207
2024
Q3 		$43.5K Buy
+519
New +$40.9K ﹤0.01% 231

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Foster Dykema Cabot & Partners's BSX Position: Q2 2026 in Review

Foster Dykema Cabot & Partners held its Boston Scientific (BSX) position steady in Q2 2026 at 400 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #245.

Foster Dykema Cabot & Partners first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $53.2K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Foster Dykema Cabot & Partners held 400 shares of Boston Scientific worth $17.1K as of Q2 2026.
  • Foster Dykema Cabot & Partners left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #245 holding.
  • Foster Dykema Cabot & Partners first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • Foster Dykema Cabot & Partners's Boston Scientific position peaked at $53.2K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.